68Ga-NK224
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 68Ga-NK224, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: 68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers